5 things we learned from EpiPen price hike hearing

September 22, 2016 2:34 PM

2 0

5 things we learned from EpiPen price hike hearing

Here's what we learned from Mylan (MYL) CEO Heather Bresch's testimony and questioning before the House Oversight panel.

Well, this shouldn't surprise you. But hearings like this bring it into full view. The hearing was heavy on rhetoric, light on answers.

Also read: Trump warns Wall Street: I'm going to cut drug prices

Read more

To category page

Loading...